Idorsia

ORG Health Care / Biotechnology Momentum 13.2 NORMAL Primary: Spectral Shift

Idorsia is a Swiss biopharmaceutical company focused on discovering and developing small molecule drugs for cardiovascular, immunological, and central nervous system disorders. The company is currently undergoing leadership transition with the search for a new CEO.

CEO transition - searching for new chief executive officer; leadership change signals potential strategic repositioning
0.00
PSI Score
13.2
Momentum
0%
Confidence
1
Connections
Connected Entities
Jazz
Watch This Entity
PSI Intelligence
30-Day Trend
2026-03-20 2026-03-27 1 0 Degree Mentions
Signal Decomposition
Attention Cascade
-2.773
Narrative Drift
0.000
Spectral Shift
445.166
Sentiment-Momentum Divergence
0.000
Source Concentration
1.000
Network Analysis
1 Degree Centrality
Centrality History
2026-03-20 2026-03-27 1 0 Degree Mentions
EntityWeight StatusFirst Seen
Jazz 1 NEW
Article Coverage (0)
DateLaneTitle

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-03-27 ← Intelligence Network